Current and potential immunohistochemical biomarkers for prognosis and therapeutic stratification of breast carcinoma. (July 2021)

• Record Type: Journal Article
• Authors: Ronchi, Andrea; Pagliuca, Francesca; Zito Marino, Federica; Accardo, Marina; Cozzolino, Immacolata; Franco, Renato
• Is Part Of: Seminars in cancer biology. Volume 72(2021)
• Page Start: 114
• Page End: 122
• Publication Date: 2021-07
• Subjects: Breast carcinoma -- Estrogen receptor -- Progesterone receptor -- HER2 -- ISH; Cancer -- Periodicals; Neoplasms -- Periodicals; Review Literature; Cancer -- Périodiques; Electronic journals; 616.994
• DOI: 10.1016/j.semcancer.2020.03.002
• Languages: English
• ISSNs: 1044-579X

Abstract

Abstract: The identification of biomarkers on cancer tissue samples could be obtained through several technologies. In this setting, the immunohistochemistry and in situ hybridization are accessible in most pathology laboratories. Particularly, immunohistochemistry can be used not only for diagnostic issues, but also to define prognostic classes and to define response to specific therapies. Particularly the last applications have been firstly developed in the breast cancer pathology. In addition, the development of molecular classification proposed some prognostic/predictive classes that could be easily defined by immunohistochemistry. Thus, the role of the pathologists has become increasingly important in the definition of prognosis and in the choice therapy, because the immunohistochemical biomarkers are used to guide treatment, to classify breast cancer into biologically and prognostically distinct subtypes. In this review, we will provide information on the current application of the immunohistochemical biomarkers useful in the management of breast cancer patients. Moreover, we consider the application of immunohistochemistry in the definition of the most promising biomarkers derived from molecular studies of the breast cancer, that in the future could integrate the characterization of breast cancer into clinical practice.